Essential

Medicines List
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES

1.1 General anaesthetics and oxygen
1.1.1 Inhalational medicines

AD0100 Halothane N01AB01 Inhalation 99.9 % v/v / / * * V

Nitrous Oxide N01AX13 Inhalation 100% v/v / / * * V
Oxygen V03AN01 Inhalation 100% / / * * V
1.1.2 Injectable medicines
50 mg (as
AB0260 Ketamine N01AX03 Injection hydrochloride) /mL in / / * * V
10-mL vial
20 mg/mL in
Propofol N01AX10 Injection / / * * E
ampoule/vial
Powder for
Thiopental N01AF03 1 g in vial / / * * E
Injection
1.2 Local anaesthetics
0.5% (hydrochloride)
AB0040 Injection / / * * V
in vial, 20 mg/4 ml
0.5% (hydrochloride)
Bupivacaine N01BB01 Injection for
in 4-mL ampoule to be
spinal / / * * V
mixed with 7.5%
anaesthesia
glucose solution
30 mg
AB0181 Ephedrine C01CA26 Injection (hydrochloride)/mL in / / * * E
1-mL ampoule
2% (hydrochloride) in
AB0270 Injection * * * * V
50-ml vial
5% (hydrochloride) in
Injection for
2-mL ampoule to be
N01BB02 spinal / / / SN V
mixed with 7.5%
Lidocaine anaesthesia
Glucose solution
Dental 2% (hydrochloride) in
* * * * V
cartridge 1.8ml cartridge
Topical
4% (hydrochloride) / / * * V
forms
2% (hydrochloride) +
Lidocaine + Epinephrine Dental
NI0220 N01BB52 Epinephrine 1:80 000 * * * * V
(Adrenaline) cartridge

1.3 Preoperative medication and sedation for short-term procedures

1 mg (sulfate) in 1-mL
AB0030 Atropine A03BA01 Injection * * * * V
ampoule
10 mg (sulfate or
Morphine N02AA01 Injection hydrochloride) in 1- / / * * V
mL ampoule

1
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

1.4 Medical gases

Oxygen V03AN01 Inhalation 100% * * * * V
2. MEDICINES FOR PAIN AND PALLIATIVE CARE

2.1 Non-opioids and non-steroidal anti-inflammatory medicines

100 mg * * * * V
Acetylsalicylic acid N02BA01 Tablet
AA0010 500 mg * * * * V
25 mg/ ml in 3-mL
M01AB05 Injection / * * * N
Diclofenac ampoule
AA0170 Tablet 50 mg (potassium salt) / * * * N
Oral liquid 20 mg/mL / * * * E
AA0590 Ibuprofen M01AE01 200 mg / * * * V
Tablet
NQ0402 400 mg / * * * V
AA0413 Oral liquid 125 mg/ 5mL * * * * V
AA0410 100 mg
Tablet * * * * V
AA0411 Paracetamol N02BE01 500 mg
Suppository 100 mg * * * * V
150 mg/mL in 2 -mL
AB0341 Injection IV * * * * V
ampoule
2.2 Opioid analgesics
Codeine
AA0156 N02AA08 Tablet 30 mg (phosphate) / / SN SN V
50 micrograms/mL in
Fentanyl N01AH01 Injection / / * * N
2- mL ampoule
10 mg (morphine
hydrochloride or
AB0320 Morphine N02AB03 Injection / / * * V
morphine sulfate) in
1-mL ampoule
5 mg (morphine
Tablet
sulfate)
Morphine (lasting 4 hours) N02AB03 (immediate / / SN SN V
release) 10 mg (morphine
sulfate)
10 mg (morphine
sulfate)
20 mg (morphine
Tablet (slow sulfate)
Morphine (lasting 12 hours) N02AB03 / / SN SN V
release) 30 mg (morphine
sulfate)
100 mg (morphine
sulfate)

2
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

5 mg (immediate
release)
Oxycodone N02AA05 Tablet / / SN SN N
20 mg (prolonged
release)
50 mg (immediate
/ / SN * V
release)
Tablet
100 mg (prolonged
Tramadol N02AX02 / / * * V
release)
100 mg/mL in 2-mL
Injection / / / * N
ampoule
2.3 Medicines used for other common symptoms in palliative care
NG0010
25 mg (hydrochloride) SN SN SN SN V
NG0011
Amitriptyline N06AA09 Tablet
50 mg (hydrochloride) / / SN SN V
Bisacodyl A06AB02 Tablet 5 mg / SN * * E
Tablet 10 mg * * * * N
Cetirizine R06AE07
Oral
1 mg/mL * * * * N
Solution
4 mg/mL in 1-mL
AB0130 Dexamethasone H02AB02 Injection ampoule (as disodium / * * * V
phosphate salt)
AB0150 Injection 10 mg/2 mL SN * * * V
Diazepam N05BA01
AA0160 Tablet 5 mg SN * * * V
20 mg/mL (as
AB0050 Hyoscine N05CM05 Injection Butylbromide) in 2- SN * * * V
mL ampoule
Lactulose A06AD11 Oral liquid 3.35 mg/ 5 mL / SN * * E
Tablet or
NQ0551 Loperamide A07DA03 2 mg / SN SN SN E
capsule
5 mg
AB0300 Metoclopramide A03FA01 Injection (hydrochloride)/mL in * * * * V
2-mL ampoule
2 mg base/mL in 4-mL
NJ0100 Injection ampoule (as / / / SN E
Ondansetron A04AA01 hydrochloride)
Tablet or
Eq. 8 mg base / / / SN E
capsule
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
4 mg (hydrogen
AA0110 Chlorpheniramine R06AB04 Tablet * * * * E
maleate)
4 mg/mL in 1-mL
AB0130 Dexamethasone H02AB02 Injection ampoule (as disodium / * * * V
phosphate salt)

3
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

50 mg/mL in 1-ml vial

AB0130 Diphenhydramine R06AA02 Injection / SN SN SN N
(as hydrochloride)
1 mg (as hydrochloride
AB0010 Epinephrine (adrenaline) C01CA03 Injection or hydrogen tartrate) in SN * * * V
1-mL ampoule
Powder for 100 mg (as sodium
AB0250 Hydrocortisone H02AB09 SN SN * * V
injection succinate) in vial
Tablet 10 mg * * * * N
Cetirizine R06AE07
Oral
1 mg/mL * * * * N
Solution
AA0470 Prednisolone H02AB06 Tablet 5 mg SN * * * V
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS
AA0101 Charcoal, activated A07BA01 Tablet 125 mg * * * * V
200 mg/mL in 10-mL
Acetylcysteine V03AB23 Injection / / SN * V
ampoule
1 mg (sulfate) in 1-mL
AB0030 Atropine A03BA01 Injection * * * * V
ampoule
100 mg/mL in 10-mL
AB0060 Calcium gluconate A12AA03 Injection SN * * * N
ampoule
Powder for 500 mg (mesilate) in
Deferoxamine V03AC01 / / SN * N
injection vial
100 micrograms/mL in
Flumazenil V03AB25 Injection / / SN * E
1-mL ampoule
Glucagon H04AA01 Injection 1 mg/mL / SN SN SN N
400 micrograms
Naloxone V03AB15 Injection (hydrochloride) in SN SN SN SN V
1-mL ampoule
Powder for
Pralidoxime V03AB04 1 gram / / SN * E
injection
5. ANTICONVULSANTS/ANTIEPILEPTICS
NG0030 Carbamazepine N03AF01 Tablet 200 mg / / SN SN V
10 mg/2 mL in
AB0150 Diazepam N05BA01 Injection SN * * * E
ampoule

Tablet or 100 mg / / SN SN E
Gabapentin N03AX12
capsule 300 mg / / SN SN E
50 mg (chewable) / / * * N
Lamotrigine N03AX09 Tablet
100 mg (chewable) / / * * N
0.5g/ mL in 10- mL
Magnesium Sulfate (only for ampoule (equivalent to
the prevention of seizures in A06AD04 Injection SN * * * V
eclampsia and preeclampsia)
5 g in 10 mL; 50%
weight/volume)

4
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

Injection 200 mg/mL (sodium) / SN * * E

AA0450
Phenobarbital N03AA02
Tablet 50 mg SN * * * V
NG0120 Tablet or
Phenytoin N03AB02 100 mg (sodium salt) SN SN * * V
capsule
500 mg (enteric
Valproic Acid (sodium N03AG01 Tablet coated, sodium / / / SN V
valproate)
valproate)
6. ANTI-INFECTIVE MEDICINES
Antimicrobial Resistance (AMR) is becoming a global health problem. To reduce AMR and assist in the development of
tools for antibiotic stewardship, WHO recommended three different categories: ACCESS, WATCH and RESERVE groups.

Group 1- "KEY ACCESS" ANTIBIOTICS

To improve both access and clinical outcomes antibiotics that were first or second choice antibiotics in at least one of the reviewed
syndromes are designated as key ACCESS antibiotics, emphasizing their role as the antibiotics that should be widely available,
affordable and quality-assured. ACCESS antibiotics are listed below. Selected (*) ACCESS antibiotics may also be included in the
WATCH group.
Beta-lactam medicines Other antibacterials
amoxicillin cefotaxime* amikacin gentamicin
amoxicillin + clavulanic acid ceftriaxone* azithromycin* metronidazole
ampicillin cloxacillin chloramphenicol nitrofurantoin
benzathine benzylpenicillin phenoxymethylpenicillin ciprofloxacin* spectinomycin (EML only)
sulfamethoxazole +
benzylpenicillin piperacillin + tazobactam* clarithromycin*
trimethoprim
Cefalexin, cefazolin procaine benzylpenicillin clindamycin vancomycin (oral)*
Cefazolin, cefixime* meropenem* clindamycin vancomycin (parenteral)*
* WATCH Group antibiotics included in the EML only for specific, limited conditions.

Group 2- "WATCH" GROUP ANTIBIOTICS

This group includes:
- antibiotic classes that have higher resistance potential and so are recommended as first or second choice treatments only for a
specific, limited number of indications. These should be prioritized as key targets of stewardship programs and monitoring.
- most of the highest priority agents among the Critically Important Antimicrobials for Human Medicine1 and/or antibiotics that
are at relatively high risk of selection of bacterial resistance.
Quinolones and fluoroquinolones: e.g. ciprofloxacin, levofloxacin, moxifloxacin
3rd generation cephalosporins (with or without beta-lactamase inhibitor): e.g. cefixime, ceftriaxone, cefotaxime, ceftazidime
Macrolides - e.g. azithromycin, clarithromycin, erythromycin; Glycopeptides - e.g. teicoplanin, vancomycin
Antipseudomonal penicillins + beta-lactamase inhibitor: e.g. piperacillin-tazobactam
Carbapenems - e.g. meropenem, imipenem + Cilastatin; Penems - e.g. faropenem

Group 3 "RESERVE" GROUP ANTIBIOTICS

This group includes antibiotics that should be treated as “last resort” options that should be accessible, but whose use should be
tailored to highly specific patients and settings, when all alternatives have failed (e.g., serious, life-threatening infections due to
multi-drug resistant bacteria). These medicines could be protected and prioritized as key targets of national and international
stewardship programs involving monitoring and utilization reporting, to preserve their effectiveness.
Aztreonam Fosfomycin (IV)
4th generation cephalosporins- e.g. cefepime Oxazolidinones - e.g. linezolid
5th generation cephalosporins - e.g. ceftaroline Tigecycline
Polymyxins - e.g. polymyxin B, colistin Daptomycin

5
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

6.1 Antihelminthics
6.1.1 Intestinal antihelminthics

NQ0004 Albendazole P02CA03 Tablet 400 mg (chewable) * * * * V

AA0280 Mebendazole P02CA01 Tablet 500 mg (chewable) * * * * V
AA0360 Niclosamide P02DA01 Tablet 500 mg (chewable) * * * * V
ND0130 Praziquantel P02BA01 Tablet 600 mg SN SN SN SN V
6.1.2 Antifilarials
NQ0004 Albendazole P02CA03 Tablet 400 mg (chewable) * * * * V
100 mg (dihydrogen
ND0230 Diethylcarbamazine P02CB02 Tablet SN SN SN SN V
citrate)
Ivermectin P02CF01 Tablet 3 mg (scored) SN SN SN SN E
6.1.3 Antischistosomals and other antitrematode medicines
ND0130 Praziquantel P02BA01 Tablet 600 mg SN SN SN SN V
6.2 Antibacterials
6.2.1 Beta-lactam medicines
Powder for 125 mg (as
AA0040 * * * * V
suspension trihydrate)/5 mL
AA0060 Amoxicillin J01CA04 250 mg (as trihydrate) * * * * V
Tablet or
AA0061 capsule 500 mg (as trihydrate)
250 mg amoxicillin +
Amoxicillin + Clavulanic Suspension 62.5 mg clavulanic / * * * V
Acid acid/5 mL
(Sepsis from respiratory focus
(moderate to severe community 500 mg (as trihydrate)
AA0050 acquired pneumonia requiring J01CR02 Tablet + 125 mg (as / * * * V
hospitalization; hospital acquired potassium salt)
pneumonia, aspiration pneumonia),
urinary tract focus, abdominal source) 1 g (as sodium) + 200
Powder for
mg (as potassium salt) / SN SN * V
injection
in vial
Powder for 1 g (as sodium salt)
AB0020 Ampicillin J01CA01 SN * * * V
injection in vial
1.44 g benzylpenicillin
Powder for
NF0040 Benzathine benzylpenicillin J01CE08 (= 2.4 million IU) in / SN SN SN V
injection
5-mL vial
3 g (= 5 million IU)
Benzylpenicillin Powder for
AB0350 J01CE01 (sodium or potassium / * * * V
(penicillin G) injection
salt) in vial
Tablet or 500 mg
Cefalexin J01DB01 / / * * E
capsule (as monohydrate)

6
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

Cefazolin
(for surgical prophylaxis Powder for 1 g (as sodium salt) in
J01DB04 / / * * N
administered within 1 hour prior injection vial
to incision)
Capsule or
NQ0101 Cefixime (WATCH) J01DD08 200 mg (as trihydrate) SN SN SN * N
Tablet
Ceftazidime (WATCH)
(Reserve for culture confirmed Powder for 1 g (as pentahydrate)
AB0081 burkholderia pseudomallei J01DD02 / / / * E
(melioidosis), b. cepacia, injection in vial
acinetobacter, p. aeruginosa)
Powder for 1 g (as sodium salt)
AB0080 Ceftriaxone (WATCH) J01DD04 / SN * * V
injection in vial
Colistin (RESERVE)
(Restricted to CPA3 with micro lab. Powder for 150 mg colistin base
Reserve for carbapenem-resistant J01XB01 / / / SN E
enterobacteriaceae cultured from injection in vial
sterile site)
500 mg (as sodium
AA0138 Capsule / * * * V
salt)
Cloxacillin J01CF02
Powder for 1 g (as sodium salt)
AB0120 / * * * V
injection in vial
Meropenem (WATCH)
(restricted to CPA3 with micro lab. Powder for 1 g (as trihydrate)
reserve for ESBL gram-negative J01DH02 / / / SN E
bacteria cultured from sterile site)
injection in vial

250 mg (as potassium

AA0440 Phenoxymethylpenicillin J01CE02 Tablet * * * * V
salt)
6.2.2 Other antibacterials
Amikacin (REVERSE)
(reserve for MDR gram-negative
500 mg (as sulfate)
GA3901 J01GB06 Injection / / / SN E
in vial
bacteria)
Azithromycin (WATCH) Capsule or
NF0030 500 mg (anhydrous) / SN SN SN V
(Culture proven salmonella, Tablet
resistant to fluoroquinolones. J01FA10
Syndromic treatment of urethritis) Oral liquid 200 mg/5 mL / * * * V

Chloramphenicol Powder for 1 g (sodium succinate)

(Restricted to CPA3 with micro J01BA01 / / / SN E
lab)
injection in vial
Ciprofloxacin (WATCH)
(Reserve as oral stepdown option 500 mg (as
AA0130 for culture proven NF gram- J01MA02 Tablet SN * * * V
negative bacteria (pseudomonas,
hydrochloride)
acinetobacter).
Tablet or
Clarithromycin (WATCH) J01FA09 500 mg / / SN * E
capsule
Tablet or 100 mg (as
AA0190 Doxycycline J01AA02 * * * * V
capsule hydrochloride)

7
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

500 mg (as stearate

AA0201 Erythromycin (WATCH) Tablet * * * * V
base)
(Alternative for PCN allergic patients. J01FA01
Powder for 125 mg/5 mL (as
AA0199 Also used as a prokinetic agent) * * * * V
oral liquid stearate base)
80 mg (as sulfate)/mL
AB0230 Gentamicin J01GB03 Injection SN * * * V
in 2-mL vial
AB0310 Injection 500 mg in 100-mL vial / * * * V
200 mg (as benzoate)/
Metronidazole J01XD01 Oral liquid * * * * V
5 mL
AA0300 Tablet 250 mg * * * * V
Nitrofurantoin J01XE01 Tablet 100 mg / / / SN V
AA0154 Suspension 200 mg + 40 mg/5 mL * * * * V
AA0151 Sulfamethoxazole + 400 mg + 80 mg * * * * V
Trimethoprim J01EE01 Tablet
NQ0111
(co-trimoxazole) 800 mg + 160 mg / SN SN SN V
80 mg + 16 mg/ mL in
Injection / SN SN SN V
5-mL ampoule
Vancomycin (WATCH)
Powder for 1 g (as hydrochloride)
(reserve for culture confirmed J01XA01 / / / SN N
injection in vial
MRSA from a sterile site)
6.2.3 Antileprosy medicines
Medicines used in the treatment of leprosy must never be used alone as monotherapy for leprosy. They are used in combination in
Multidrug Therapy (MDT). Combination therapy is essential to prevent the emergence of drug resistance.
NC0120 Clofazimine J04BA01 Capsule 100 mg / * * * V
NQ0156 Dapsone J04BA02 Tablet 100 mg / SN SN SN V
Tablet or
NC0083 Rifampicin [R] J04AB02 150 mg / * * * V
capsule
NC0020 Multibacillary (MB) Leprosy Adult * * * * V
NC0030 Multibacillary (MB) Leprosy Child Colour- * * * * V
Multi-drug therapy
coded
NC0040 Paucibacillary (PB) Leprosy Adult (MDT) * * * * V
blister packs
Paucibacillary (PB) Leprosy
NC0050 Child * * * * V
6.2.4 Antituberculosis medicines
Antituberculosis medicines should be used according to the national treatment guidelines.
NC009 100 mg
Ethambutol [E] J04AK02 Tablet * * * * V
NC0010 400 mg
Ethambutol + Isoniazid + 275 mg + 75 mg
NC0082 J04AM06 Tablet * * * * V
Pyrazinamide + Rifampicin +400 mg + 150 mg
NC0011 100 mg
Isoniazid [H] J04AC01 Tablet / * * * V
300 mg

8
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

NC0081 Isoniazid + Pyrazinamide + 50 mg + 150 mg +

J04AM05 Tablet * * * * V
Rifampicin + 75 mg
NC0071
Tablet 75 mg + 150 mg * * * * V
NC0069
Isoniazid + Rifampicin J04AM02
Tablet 50 mg + 75 mg * * * * V
NC0060
Pyrazinamide [Z] J04AK01 Tablet 400 mg / * * * V
NC0083 Tablet or
Rifampicin [R] J04AB02 150 mg / * * * V
capsule
Reverse second-line drugs for the treatment of multidrug-resistance tuberculosis (MDR-TB) must be used in TB clinics adhering to
the national treatment guidelines.
Powder for 500 mg (as sulfate)
GA3901 Amikacin (RESERVE) J01GB06 / / / SN E
injection in vial
Bedaquiline (RESERVE) J04AK05 Tablet 100 mg / / / SN E
Powder for
Capreomycin (RESERVE) J04AB30 1 g (as sulfate) in vial / / / SN E
injection
Clofazimine (RESERVE) J04BA01 Capsule 100 mg / / / SN E
Tablet or
Cycloserine (RESERVE) J04AB01 250 mg / / / SN E
capsule
Ethionamide (RESERVE) J04AD03 Tablet 250 mg / / / SN E
Powder for
NC0015 Kanamycin (RESERVE) J01GB04 1 g (as sulfate) in vial / / / SN E
injection
Levofloxacin J01MA12 Tablet 250 mg / / / SN E
Linezolid (RESERVE) J01XX08 Tablet 600 mg / / / SN E
Moxifloxacin (RESERVE) J01MA14 Tablet 400 mg / / / SN E
AA0400 Ofloxacin (RESERVE) J01MA01 Tablet 200 mg / / / SN E
p-aminosalicylic acid J04AA01 Granules 4 g in sachet / / / SN E
(RESERVE)
Prothionamide J04AD01 Tablet 250 mg / / / SN E
Powder for
NC0092 Streptomycin (RESERVE) J01GA01 1 g (as sulfate) in vial SN * * * E
injection
6.3 Antifungal medicines
50 mg in vial (as
Powder for
AB0022 Amphotericin B J02AA01 sodium deoxycholate / SN SN SN V
Injection
or liposomal complex)
Tablet 100 mg * * * * V
G01AF02
Vaginal
NF0100 Clotrimazole 500 mg SN SN SN SN V
tablet
Topical
NQ2286 D01AC01 1% / * * * V
cream
Tablet or
AA0221 Fluconazole J02AC01 200 mg SN * * * E
capsule

9
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

Tablet or
NF0130 Griseofulvin D01BA01 500 mg * * * * V
capsule
Tablet or
Itraconazole J02AC02 200 mg / SN SN SN E
capsule
AA0380 Nystatin G01AA01 Tablet 500 000 IU SN * * * V

6.4 Antiviral medicines

6.4.1 Antiherpes medicines
NF0010 200 mg
Aciclovir J05AB01 Tablet / SN SN SN V
NF0011 400 mg

6.4.2 Antiretrovirals
These medicines should be used according to the national treatment guidelines of HIV/AIDS.
6.4.2.1 Nucleoside/Nucleotide reverse transcriptase inhibitors
60 mg (as sulfate)
Abacavir (ABC) J05AF06 Tablet SN SN SN SN V
NE0010 300 mg (as sulfate)
NE0070 Lamivudine (3TC) J05AF05 Tablet 150 mg SN SN SN SN V

NE0270 Tenofovir disoproxil fumarate J05AF07 Tablet 300 mg SN SN SN * V

(TDF)
NE0302 Zidovudine J05AF01 Oral liquid 50mg/5ml SN SN SN SN V
6.4.2.2 Non-nucleoside reverse transcriptase inhibitors
200 mg
NE0051 400 mg
Efavirenz (EFV or EFZ) J05AG03 Capsule SN SN SN SN V
NE0052 600 mg
25 mg
Etravirine (ETV) J05AG04 Tablet SN SN SN SN V
100 mg
NE0180 Oral liquid 50 mg/5 mL
Nevirapine (NVP) J05AG01 SN SN SN SN V
NE0170 Tablet 200 mg
6.4.2.3 Protease inhibitors
300 mg (as sulfate)
NE0015 Atazanavir + Ritonavir Tablet SN SN SN SN V
+100 mg
NE0047 75 mg
Darunavir J05AE10 Tablet 150 mg SN SN SN SN V
600 mg

10
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

400 mg + 100 mg/

NE0150 Oral Liquid
5 mL SN SN SN SN V
NE0142 Capsule 100 mg + 25 mg
Lopinavir + Ritonavir (LPV/r) J05AR10
NE0141 Capsule 200 mg + 50 mg
SN SN SN SN V
NE0143 Tablet 40 mg + 10 mg
NE0220 Ritonavir J05AE03 Tablet 100 mg SN SN SN SN V
6.4.2.4 Integrase Inhibitors
NE0048 Dolutegravir J05AX12 Tablet 50 mg SN SN SN SN V
Raltegravir J05AX08 Tablet 25 mg SN SN SN SN V
FIXED - DOSE COMBINATIONS

NE0017
120 mg (as sulfate) +
+60 mg
Abacavir + Lamivudine J05AR02 Tablet SN SN SN SN V
NE0014
600 mg (as sulfate) +
+300 mg
Abacavir + Lamivudine +
60 mg + 30 mg +
Zidovudine J05AR04 Capsule SN SN SN SN V
+60 mg
Efavirenz + Lamivudine + 600 mg + 300 mg +
NE0271 J05AR11 Tablet SN SN SN SN V
Tenofovir +300 mg
NE0111
30 mg + 50 mg +
Lamivudine + Nevirapine + +60 mg
J05AR05 Tablet SN SN SN SN V
NE0011 Zidovudine 150 mg + 200 mg +
4 +300 mg
300 mg + 300 mg
NE0272 Lamivudine + Tenofovir J05AR12 Tablet SN SN SN SN V
(disoproxil fumarate)
NE0113 Lamivudine + Zidovudine J05AR01 Tablet 30 mg + 60 mg SN SN SN SN V
6.4.3 Antihepatitis medicines
6.4.3.1 Medicines for Hepatitis B
6.4.3.1.1 Nucleoside/nucleotide reverse transcriptase inhibitors
Tablet 500 micrograms
Entecavir J05AF10 / / / * N
Oral liquid 50 micrograms/ mL
Tenofovir disoproxil fumarate 300 mg (equivalent to
(TDF) J05AF07 Tablet 245 mg tenofovir / / / * V
disoproxil)
6.4.3.2 Medicine for Hepatitis C
6.4.3.2.1 Nucleotide polymerase inhibitors
Sofosbuvir J05AX15 Tablet 400 mg / / / * V

11
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

6.4.3.2.2 NS5A inhibitors

30 mg (as
hydrochloride)
Daclatasvir J05AX14 Tablet / / / * N
60 mg (as
hydrochloride)
6.4.3.2.3 Other antivirals
Ribavirin 200 mg
(in combination with with Tablet or
J05AB04 / / / * N
peginterferon and/or DAA capsule 400 mg
medicines)
FIXED- DOSE COMBINATIONS

Ledipasvir + Sofosbuvir J05AX65 Tablet 90 mg + 400 mg / / / * E

6.5 Antiprotozoal medicines
6.5.1 Antiamoebic and antigiardiasis medicines
AB0310 Injection 500 mg in 100- mL
/ * * * V
vial
Metronidazole P01AB01 Oral liquid 200 mg (as benzoate)/
* * * * V
5 mL
AA0300 Tablet 250 mg * * * * V
6.5.2 Antileishmaniasis Medicines
50 mg in vial (as
Powder for
AB0022 Amphotericin B J02AA01 sodium deoxycholate / SN SN SN V
Injection
or liposomal complex)
6.5.3 Antimalarial medicines

The use of antimalarial medicines should be based on the national treatment guidelines of malaria to avoid drug-resistance. Medicines
for the treatment of P. falciparum malaria cases should be used in combination.
6.5.3.1 For curative treatment
Oily 80 mg/ mL in 1- mL
ND0040 Artemether P01BE02 SN * * * V
injection ampoule
60 mg anhydrous
artesunic acid with a
ND0041 Artesunate P01BE03 Injection separate ampoule of SN * * * V
5% sodium
bicarbonate solution
ND0056
25 mg + 50 mg
(blister/3 Tabs)
25 mg + 50 mg
Tablet (blister/6 Tabs)
Artesunate + Mefloquine P01BF02 * * * * V
(FDC) 100 mg + 200 mg
(blister/3 Tabs)
ND0058
100 mg + 200 mg
(blister/6 Tabs)

12
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

ND0051
Rectal 50 mg * * * * V
Artesunate rectocap P01BE03
ND0051 dosage form 200 mg * * * * V
100 mg (as
AA0190 Doxycycline J01AA02 Capsule * * * * V
hydrochloride)
Primaquine base P01BA03 Tablet 15 mg (as diphosphate) SN * * * E
300 mg quinine
ND0140 Injection hydrochloride/ mL in SN * * * V
2- mL ampoule
Quinine P01BC01
300 mg (quinine
ND0150 Tablet sulfate) or 300 mg SN * * * V
(quinine bisulfate)
6.5.4 Antipneumocystosis and antitoxoplasmosis medicines
AA0153 Oral liquid 200 mg + 40 mg/5mL * * * * V
Sulfamethoxazole +
AA0151
Trimethoprim J01EE01 400 mg + 80 mg
AA0152 (co-trimoxazole) Tablet / SN SN SN V
800 mg + 160 mg

7. ANTIMIGRAINE MEDICINES
7.1 For treatment of acute attack
AA0010 Acetylsalicylic acid N02BA01 Tablet 500 mg * * * * V
AA0590 200 mg / * * * V
Ibuprofen M01AE01 Tablet
NQ0402 400 mg / * * * V
AA0410 100 mg
Tablet * * * * V
AA0411 Paracetamol N02BE01 500 mg
AA0413 Oral liquid 125 mg/5 mL * * * * V
7.2 For Prophylaxis
Propranolol C07AA05 Tablet 40 mg (hydrochloride) / * * * V
8. ANTINEOPASTICS AND IMMUNOSUPPRESSIVES

8.1 Cytotoxic and adjuvant medicines

M04AA0
Allopurinol 1 Tablet 100 mg * * * * E
Powder for
Asparaginase L01XX02 10 000 IU in vial / / / SN E
injection
Powder for 15 mg (as sulfate) in
NJ0010 Bleomycin L01DC01 / / / SN V
injection vial
Carboplatin L01XA02 Injection 150 mg/15 mL / / / SN N
NJ0020 Cisplatin L01XA01 Injection 50 mg/50 mL / / / SN E

13
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

Powder for
NJ0030 Cyclophosphamide L01AA01 500 mg in vial / / / SN N
injection
Cytarabine Powder for 100 mg in vial
L01BC01 / / / SN V
injection
Powder for
NJ0040 Dacarbazine L01AX04 100 in vial / / / SN N
injection
500 micrograms in
Dactinomycin L01DA01 Injection / / / SN N
vial
Tablet 500 mg / / / SN N
Daferiprone V03AC02
Oral
100 mg / / / SN N
suspension
Powder for 50 ml (hydrochloride)
Daunorubicin L01DB02 / / / SN E
injection in vial
Powder for 50 mg (hydrochloride)
NJ0050 Doxorubicin L01DB01 / / / SN E
injection in vial
20 mg/mL in 5-mL in
NJ060 Etoposide L01CB01 Injection / / / SN V
ampoule
50 mg/mL in 5-mL
NJ0070 Fluorouracil L01BC02 Injection / / / SN E
ampoule
Ifosfamide L01AA06 Injection 1 g in vial / / / SN E
Powder for 50 mg (as sodium salt)
NJ0080 Methotrexate L04AX03 / / / SN V
injection in vial
NJ0090 Mitomycin L01DC03 Injection 2 mg in ampoule / / / SN N
Powder for
Vinblastine L01CA01 10 mg (sulfate) in vial / / / SN V
injection
Powder for 1 mg/ml (sulfate)
NJ0130 Vincristine L01CA02 / / / SN V
injection in vial
8.2 Hormones and antihormones
4 mg/mL in 1-mL
AB0130 Dexamethasone H02AB02 Injection ampoule (as disodium / * * * V
phosphate salt)
Powder for 100 mg (as sodium
AB0250 Hydrocortisone H02AB09 SN SN * * V
injection succinate) in vial
AA0470 Prednisolone H02AB06 Tablet 5 mg SN * * * V
NJ0120 Tamoxifen L02BA01 Tablet 20 mg (as citrate) / / / SN V

9. ANTIPARKINSONISM MEDICINES
NG0020 Benztropine mesylate N04AC01 Injection 2 mg/ml / / / SN V
Levodopa + carbidopa N04BA02 Tablet 250 mg + 25 mg / / / SN V
NJ0120 Tablet 5 mg SN SN SN SN N
Trihexyphenidyl N04AA01
Injection 10 mg/5 ml / / / SN N

14
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

10. MEDICINES AFFECTING THE BLOOD

10.1 Antianaemia medicines
AA0212 Ferrous Fumarate B03AA02 Suspension 100 mg/5 ml * * * * V
Ferrous Salt + Folic Acid equivalent to 60 mg
AA0210 (supplement to use during B03AD03 Tablet iron + 400 micrograms * * * * V
pregnancy) folic acid
AA0230 Folic Acid B03BB01 Tablet 5 mg * * * * V
1 mg (as acetate, as
Hydroxocobalamin hydrochloride or as
B03BA03 Injection / / SN * V
(Vitamin B12) sulfate) in 1-mL
ampoule
10.2 Medicines affecting coagulation
AB0200 Etamsylate Injection 250 mg/ 2 ml in vial / / * * V
5 000 IU/mL in
Heparin sodium B01AB01 Injection / / SN SN V
ampoule
1 mg/ml in ampoule
Phytomenadione B02BA01 Injection 10 mg/1 ml in 5-mL * * * * V
AB0420 (Vitamin K1)
ampoule
100 mg/ mL in 5-mL
Tranexamic acid B02AA02 Injection / / * * E
ampoule
11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES
11.1 Plasma- derived medicines
11.1.1 Human immunoglobulins
Antirabies immunoglobulin J06BB05 Injection 150 IU/mL in vial / SN SN SN E
NB0020 Antitetanus immunoglobulin J06BB02 Injection 1500 IU/1mL in vial / / * * V
11.2 Plasma Substitutes
Hydroxyethyl Starch (HES)
B05AA07
in isotonic sodium chloride Injection 6% HES 130 / 0.4 / / * * V
solution
12. CARDIOVASCULAR MEDICINES
12.1 Antianginal medicines
AA0550 Isosorbide dinitrate C01DA08 Tablet 10 mg / * * * V
12.2 Antiarrhythmic medicines
50 mg/mL in 3-mL
Injection ampoule / / SN * N
Amiodarone C01BD01 (hydrochloride)
100 mg
Tablet / / SN * N
(hydrochloride)

15
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

3 mg/mL in 2- mL
Adenosine C01EB10 Injection / / SN * E
ampoule
250 micrograms/mL in
AB0160 Injection / / * * V
Digoxin C01AA05 2-mL
AA0180 Tablet 250 micrograms / * * * V
1 mg (as hydrochloride
AB0010 Epinephrine (Adrenaline) C01CA24 Injection or hydrogen tartrate) in SN * * * V
1- mL
12.3 Antihypertensive medicines
5 mg (as maleate,
AA0081 Amlodipine C08CA01 Tablet * * * * V
mesylate or besylate)
AA0080 Atenolol C07AB03 Tablet 50 mg * * * * V
10 mg (as hydrogen
AA0202 Enalapril C09AA02 Tablet / / SN SN V
maleate)
Powder for 20 mg (hydrochloride)
AB0240 SN * * * V
Hydralazine C02DB02 injection in ampoule
AA0250 Tablet 25 mg (hydrochloride) * * * * V
AA0260
Scored 25 mg
Hydrochlorothiazide C03AA03 * * * * V
tablet 50 mg
Methyldopa
(for use only in the management
AA0290 C02AB01 Tablet 250 mg SN * * * V
of pregnancy-induced
hypertension)
Nicardipine C08CA04 Injection 10 mg/50 ml in bottle / / SN * N
20 mg (modified
AA0370 / * * * V
release)
Nifedipine C08CA05 Tablet
10 mg (immediate
/ SN SN SN E
release)
Tablet
Losartan potassium C09CA01 (film- 50 mg / SN SN * E
coated)
12.4 Medicines used in heart failure
AA0155 Captopril C09AA01 Tablet 25 mg SN * * * V
AA0180 Tablet 250 micrograms / * * * V
Digoxin C01AA05
250 micrograms/mL in
AB0160 Injection / / * * E
2-mL ampoule
5 mg/mL (as
Dobutamine C01CA07 Injection / SN SN SN E
hydrochloride)
40 mg/mL in
5-mL vial
AB0170 Dopamine C01CA04 Injection / / SN * E
(hydrochloride)

16
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

10 mg (as hydrogen
AA0202 Enalapril C09AA02 Tablet / / SN SN V
maleate)
10 mg/mL in 2-mL
AB0220 Injection / * * * V
Furosemide C03CA01 ampoule
AA0240 Tablet 40 mg SN * * * V
AA0260
Scored 25 mg
Hydrochlorothiazide C03AA03 * * * * E
tablet 50 mg

Losartan potassium C09CA01

Tablet (flim- 50 mg / SN SN * E
coated)
12.5 Antithrombotic medicines
12.5.1 Antiplatelet medicines
Acetylsalicylic acid B01AC06 Tablet 100 mg * * * * V
12.5.2 Thrombolytic medicines
Powder for
Streptokinase B01AD01 1.5 million IU in vial / / SN SN E
injection
12.5.3 Lipid - lowering agents
AA0203 Fenofibrate C10AB05 Tablet 200 mg / / * * N
20 mg (for use in high-
AA0505 Simvastatin C10AA01 Tablet / / * * E
risk patients)
13. DERMATOLOGICAL ITEMS (topical)
13.1 Anti-infective and antifungal medicines
AD0270 Aciclovir D06BB03 10g 5% / SN SN * E
AD0010 Benzoic acid + salicylic acid D01AE20 Ointment 6%+3% (500 g/Jar) * * * * V
NQ2286 Clotrimazole D01AC01 Cream 1% / * * * V
NF0120 Fusidic acid D09AA02 Cream 2% / SN SN SN V
NF0180 Ketoconazole D01AC08 Cream 2% / SN SN * V
Cream or
NP0190 Miconazole D01AC02 2% (nitrate) SN SN SN SN V
Ointment
13.2 Anti-inflammatory, antipruritic medicines and treatment of acne vulgaris
Betamethasone Cream or
D07AC01 0.1% (as valerate) SN SN SN SN E
Ointment
Betamethasone + salicylic D07XC01 Cream or
0.05% + 3% / SN SN SN E
acid Ointment
NF0082 Lotion 0.05% / SN SN SN E
Clobetasole propionate D07AD01
NF0080 Cream 0.05% / SN SN SN E
NF0151 Hydrocortisone Cream or 1 % (acetate)
D07AA02 SN SN SN SN V
Ointment
17
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

Triamcinolone acetonide D07AB09 Cream 0.10% / SN SN SN V

Tretinoin D10AD01 Cream 0.05% / SN SN SN E
13.3 Medicines affecting skin differentiation and proliferation
Cream or
Benzoyl Peroxide D10AE01 5% / SN SN SN E
Lotion
D02AE01
Urea Cream 10% / SN SN SN E
13.4 Scabicides and pediculicides

AD0020 Benzyl benzoate P03AX01 Lotion 25% * * * * E

NF0112 Crotamiton - Cream 10% / SN SN SN E
14. DIAGNOSTIC AGENTS
14.1 Ophthalmic Medicines
NA0051 Fluorescein S01JA01 Eye drops 2% / / SN * E
NA0130 Tropicamide S01FA06 Eye drops 1% / / SN * E
15. DISINFECTANTS AND ANTISEPTICS
15.1 Antiseptics
20% 1 Litre/bottle
AD0040 Chlorhexidine D08AC02 Solution (digluconate) * * * * V

10% (equivalent to 1%
AD0140 Povidone iodine D08AG02 Solution available iodine) * * * * V

15.2 Disinfectants
Containing ethanol
- * * * * V
80% volume/volume
Alcohol based hand rub Solution
Containing isopropyl
alcohol 75% v/v
Chlorine dioxide - Solution 500 mL * * * * V
NQ5121 Ethanol Solution 96% V/V * * * * V
Glutaral - Solution 2% * * * * V
XA1410 Glycerol Solution 98% * * * * V
Isopropyl alcohol Solution 99.80% * * * * V
Peracetic Acid Solution 0.20% * * * * V
Sodium Hypochlorite D08AX07 Solution 5% * * * * V
Powder for
Zinc oxide * * * * N
solution

18
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

16. DIURETICS
10 mg/mL in 2-mL
AB0220 Injection / * * * V
Furosemide C03CA01 ampoule
AA0240 Tablet 40 mg SN * * * V
AA0260
Scored 25 mg
Hydrochlorothiazide C03AA03 * * * * V
tablet 50 mg
17. GASTROINTESTINAL MEDICINES
17.1 Antiulcer medicines
Aluminium Hydroxide + A02AD03 Tablet 125 mg + 250 mg * * * * N
Magnesium Hydroxide
AA0120 Tablet 200 mg * * * * E
A02BA01
Cimetidine 200 mg/ 2ml in
AB0110 Injection / * * * E
ampoule
Powder for
40 mg in vial / / SN * E
Omeprazole A02BC01 injection
NQ0735 Tablet 20 mg / * * * V
17.2 Antiemetic medicines
4 mg/ mL in 1- mL
AB0130 Dexamethasone A01AC02 Injection ampoule (as disodium / * * * V
phosphate salt)
Domperidone A03FA03 Tablet 10 mg SN SN * * N
5 mg (hydrochloride)/
AB0300 Metoclopramide A03FA01 Injection * * * * E
mL in 2- mL ampoule
2 mg base/mL in 4-mL
NJ0100 Injection ampoule (as / / / SN E
Ondansetron A04AA01 hydrochloride)
Tablet or
Eq. 8 mg base / / / SN E
capsule
17.3 Laxatives
Bisacodyl A06AB02 Tablet 5 mg / SN * * N
17.5 Medicines used in diarrhea
17.5.1 Oral rehydration
Powder for dilution in sachet.
Reduced osmalarity ORS grams/litre: glucose-
13.5 g/L; sodium chloride-2.6 g/L; potassium
chloride- 1.5 g/L; trisodium citrate dihydrate-
AA0390 Oral rehydration salts (ORS) A07CA 2.9 g/L. Reduced osmolarity ORS mmol/Litre: * * * * V
glucose- 75 mEq; sodium- 75 mEq or mmol/L;
chloride- 65 mEq or mmol/L; potassium- 20
mEq or mmol/L; citrate- 10 mmol/L.
Total osmolarity: 245

19
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

17.5.2 Medicines for diarrhea

Tablet
NL0040 Zinc sulphate A12CB01 20 mg * * * * V
(dispersible)
18. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
18.1 Contraceptives
18.1.1 Oral hormonal contraceptives
Ethinyloestradiol + 30 micrograms + 150
NH0050 Levonorgestrel + Ferrous G03AA07 Tablet micrograms+ 75 mg * * * * V
Fumarate (COC)
30 micrograms (POP)
NH0053 G03AC03 1 pack=3 cycles/35 * * * * V
Levonorgestrel Tablet tablets
G03AD01 1.5 mg (as emergency
NH0052 * * * * V
contraception)
18.1.2 Injectable hormonal contraceptives
Injection
Medroxyprogesterone acetate 150 mg/ mL in 1- mL
NH0020 G03AC06 (intra- * * * * V
(depo-provera) vial
muscular)
18.1.3 Intrauterine devices
Intrauterine copper-
NH0030 G02BA02 IUD Copper T380A * * * * V
containing device
18.1.4 Barrier methods
NH0010 Condoms V07AY 49 mm * * * * V

18.1.5 Implantable contraceptives

Etonogestrel- releasing Single- rod contains 68 mg of
G03AC08 * * * * V
implant (subdermal) implant etonogestrel
each rod containing 75
Levonorgestrel- releasing Two-rod
G03AC03 mg of levonorgestrel * * * * V
implant (subdermal) implant
(150 mg total)
18.2 Insulins and other medicines used for diabetes
NK0010 Glibenclamide A10BB01 Tablet 5 mg SN * * * E
NK0031 Insulin, long- acting A10AE01 Injection 100 IU/ mL / SN SN SN V
40 IU/mL in 10-mL
NK0032 / SN SN SN V
Insulin, rapid acting A10AB01 vial
Injection
(3-6 hours) 100 IU/mL in 10-mL
NK0033 / SN SN SN V
vial
Premixed Insulin 70/30
NK0034 A10AD01 Injection 100 IU/mL / / SN SN V
(Semi-lente 70/ Rapid 30)
500 mg
NK0040 Metformin A10BA02 Tablet SN * * * V
(hydrochloride)

20
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

18.3 Thyroid hormone and antithyroid hormones

5 mg / / SN SN N
Carbimazole H03BB01 Tablet
20 mg / / SN SN N
50 micrograms
Levothyroxine H03AA01 Tablet / / SN SN V
(sodium salt)
Propylthiouracil H03BA02 Tablet 50 mg / / SN SN E
19. IMMUNOLOGICALS/BIOLOGICALS
Biological products, including vaccines, are distinguished from chemical pharmaceuticals by being derived from living organisms with
a molecular composition too complex to be defined by physical or chemical means. In addition, the inherent variability of living
organisms, the potential for contamination of materials with agents coming from starting materials or the environment, require special
quality control and quality assurance mechanisms. To maintain quality, biological must be protected from temperature extremes. Heat
exposure must be monitored using Vaccine Vial Monitors (VVM) throughout the entire supply chain.
19.1 Vaccines
0.05 mL in 20 doses
BCG (Bacille Calmette-Guerin) vaccine ATC code:
NB0031 vial with VVM * * * * V
with diluent L03AX03
(vaccine vial monitor)
DTP-Hep B-Hib
(Diphteria, Tetanus,whole-cell Pertussis 0.5 mL in single- dose
NB0033 J07CA11 * * * * V
[DTP], Hepatitis B and Haemophilue vial with VVM
influenza type B)
0.5 mL in single dose
NB0051 Hepatitis B vaccine J07BC01 * * * * V
vial with VVM
0.5 mL in 2 doses vial
NB0049 Human papillomavirus (HPV) vaccine J07BM03 * * * * V
with VVM
Japanese encephalitis (JE) vaccine with 0.5 mL in 5 doses vial
NB0053 J07BA03 * * * * V
diluent with VVM
Measles + Rubella (MR) vaccine with 0.5 mL in 10 doses
NB0071 J07BD53 * * * * V
diluent vial with VVM
Pneumococcal conjugate vaccine 13 0.5 mL in single- dose
NB0028 J07AL02 * * * * V
(PCV13) vial with VVM
0.5 mL in 5 doses vial
NB0064 Inactivated Poliomyelitis vaccine J07BF03 * * * * V
with VVM
2 drops at dose, 10
NB0062 Oral Poliomyelitis vaccine with dropper J07BF04 * * * * V
doses vial with VVM
2.5 IU/ml in 1- mL
Rabies vaccine J07BG01 SN SN SN SN V
ampoule
0.5 mL in 10 doses in
NB0028 Tetanus toxoid vaccine J07AM01 * * * * V
vial
19.2 Sera and immunoglobulins
10 000 IU or 20 000
Diphteria antitoxin J06AA01 Injection: / * * * V
IU in vial
NB0011 Hematoxic polyvalent snake Freeze-dried
antivenom (HPAV) Powder for antivenom in vial to
J06AA03 / * * * V
( Asian snakes as Malayan Pit injection be reconstituted with
Viper, Green Pit Viper and the solution supplied
21
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

Russell's Viper (or 10 ml of sterile

water for injection)
NB0012 Neurotoxic polyvalent snake prior to the
antivenom (NPAV) administration
J06AA03 / * * * V
Cobra, King Cobra, Banded
Krait & Malayan Krait snakes
20. MUSCLE RELAXANTS (PERIPHERALLY- ACTING) AND CHOLINESTERASE INHIBITORS
500 micrograms in
AB0330 Neostigmine N07AA01 Injection / / * * V
1- mL ampoule
50 mg (chloride)/ mL
AB0392 Suxamethonium M03AB01 Injection / / * * E
in 2- mL ampoule
Powder for 4 mg (bromide)/1 mL
AB0410 Vecuronium M03AC03 / / * * N
injection in vial with diluent
21. OPTHALMOLOGICAL PREPARATIONS
21.1 Anti-infective agents
Moxifloxacin S01AE07 Eye drops 0.50% / / SN * E
Natamycin S01AA10 Eye drops 5% (eye drops) / / SN * E
Neomycin - polymycin B - NA Eye drops - / / SN * E
dexamethasone
Eye
NQ3142 Tetracycline S01AA09 1% (hydrochloride) * * * * E
ointment
Tobramycin S01CA01 Eye drops 0.30% * * * * E
21.2 Anti-inflammatory agents
Fluorometholone D07XB04 Eye drops 0.10% / / SN * E
Olopatadine S01GX09 Eye drops 1 mg/mL / / SN * E
NA0108 Prednisolone S02BA03 Eye drops 1% / / SN * E
21.3 Local anaesthetics
Solution
NA0110 Tetracaine S01HA03 0.5% (hydrochloride) / / SN * E
(eye drops)
21.4 Miotics and antiglaucoma medicines
Acetazolamide S01EC01 Tablet 250 mg / / SN * E
2% (3 ml pre – filled
Hydroxypropyl Intraocular
NA0071 S01KA02 syringe pack) / / SN * N
methylcellulose injection
2% (as sodium
NA0100 Pilocarpine S01EB01 Eye drops / / SN * E
phosphate)
0.5% (as hydrogen
NA0100 Timolol S01ED01 Eye drops / / SN * E
maleate)
Travoprost (Travatan) S01EE04 Eye drops 0.004% / / / * E

22
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

21.5 Mydriatics
NA0020 Atropine S01FA01 Eye drops 1% (sulfate) / / SN * E
21.6 Antivascular endothelial growth factor (VEGF) preparations
Bevacizumab L01XC07 Injection 25 mg/ml , 4 ml-vial / / / * E
22. OXYTOCICS AND ANTIOXYTOCICS
22.1 Oxytocics
Depending upon the manufacturer, oxytocin products should be stored at either controlled room temperature (25°C or less) or in
refrigerated storage (2°- 8°C) in order to ensure quality and comply with the labelled storage conditions.
200 micrograms
AB0190 Ergometrine G02AB03 Injection (hydrogen maleate) in SN SN SN SN V
1-mL ampoule
Combi pack of 200 mg
Tablet/
(single)- four vaginal
Mifepristone-misoprostol G03XB51 vaginal SN SN SN SN N
tablets of 200
tablet
micrograms
AA0330 Misoprostol G02AD06 Tablet 200 micrograms / SN * * V
10 IU in 1-mL in
AB0440 Oxytocin G02AC01 Injection * * * * V
ampoule
22.2 Antioxytocics (tocolytic)
10 mg (immediate
Nifedipine C08CA05 Capsule / SN SN SN E
release)
23. MEDICINES FOR MENTAL AND BEHAVIORAL DISORDERS
23.1 Medicines used in psychotic disorders
AB0100 25 mg (hydrochloride)/
/ / SN SN V
mL in 2- mL ampoule
NG0041 Injection
Chlorpromazine N05AA01 25 mg (hydrochloride) SN * * * V
Tablet
100 mg
SN SN SN SN V
(hydrochloride)
Tablet or
Clozapine N05AH02 100 mg / / SN SN E
capsule
NG0060 25 mg (decanoate or
Fluphenazine N05AB02 Injection enantate) in 1- mL / / / SN V
ampoule
NG0070
5 mg / / SN SN V
NG0071
Tablet
Haloperidol N05AD01 10 mg / / SN SN V
NG0073 5 mg in 1- mL
Injection / / SN SN V
ampoule
Risperidone N05AX08 Tablet 2 mg / / / SN V
Olanzapine N05AH03 Tablet 10 mg / / / SN E

23
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

NG0110
Perphenazine N05AB03 Tablet 8 mg / / SN SN E
NG0130 Thioridazine N05AC02 Tablet 10mg / / SN SN E
23.2 Medicines used in mood disorders
23.2.1 Medicines used in depressive disorders

NG0010 25 mg (hydrochloride) SN SN SN SN V
Amitriptyline N06AA09 Tablet
NG0011 50 mg (hydrochloride) / / SN SN V
Tablet or 20 mg (as
Fluoxetine N06AB03 / / / SN V
capsule hydrochloride)
NG0081 Imipramine N06AA02 Tablet 25 mg / SN SN SN N
NGNG0 N06AA10 25 mg (as
Nortriptyline Tablet / / SN SN E
100 hydrochloride)
23.2.2 Medicines used in bipolar disorder
NG0030 Carbamazepine N03AF01 Tablet 200 mg / / SN SN V
NG0090 Lithium carbonate N05AN01 Tablet 300 mg / / SN SN V
500 mg (sodium
Valproic acid N03AG01 Tablet / / / SN V
valproate)
23.3 Medicines for anxiety disorders
AA0160 Diazepam N05BA01 Tablet 5 mg SN * * * V
23.4 Medicines for obsessive compulsive disorders
NG0050 Clomipramine N06AA04 Capsule 25 mg (hydrochloride) / / SN SN E

23.5 Medicines used in disorders due to psychoactive substance use

Chewing
2 mg / SN SN SN N
Nicotine replacement therapy gum
N07BA01
(NRT) Transdermal
14 mg / SN SN SN N
patch
concentrate
10 mg/mL (as
NG0096 Methadone N07BC02 for oral / SN SN SN E
hydrochloride)
liquid
24. MEDICINE ACTING ON THE RESPIRATORY TRACT
24.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease
AA0030 Aminophylline R03DA05 Tablet 100 mg / * * * E
100 micrograms
Beclometasone R03BA01 Inhalation / / * * E
per dose
1 mg (as hydrochloride
AB0010 Epinephrine (adrenaline) R03AA01 Injection or hydrogen tartrate) in SN * * * V
1- mL ampoule

24
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

Inhalation 20 micrograms/
Ipratropium bromide R03BB01 / / * * V
(aerosol) metered doses
AA0500 Tablet 4 mg * * * * E
100 micrograms (as
Aerosol SN * * * V
Salbutamol R03AC02 sulfate) per dose
0.5 mg (as sulfate)/ mL
AB0370 Injection in 1- mL ampoule / * * * E

24.2 Mucolytic agent

AA0090 Tablet 8 mg * * * * E
Bromhexine R05CB02
4 mg/5 ml in 60 ml
AA0640 Oral liquid * * * * E
bottle
25. SOLUTIONS CORRECTING WATER, ELECTROLYTE ND ACID-BASE DISTURBANCES
25.1 Oral
Powder for
AA0390 Oral rehydration salts A07CA see 17.5.1 * * * * V
dilution
Powder for
AA0460 Potassium chloride A12BA01 600 mg SN * * * E
solution
25.2 Parenteral
5% (isotonic) in 500
AC0020 * * * *
Injectable mL
solution 10% (hypertonic) in
AC0031 Glucose/Dextrose B05CX01 500 mL SN * * * V
with IV
giving set
AB0140 50% in 50- mL vial SN * * *
5% glucose in 1/3
AC0036 / SN SN SN
NaCl - 500 mL
Injectable 5% glucose, 0.225 %
/ * * *
Glucose (5%) + sodium solution NaCl - 500 mL
B05BB02 V
chloride (or Saline) with IV 5% glucose, 0.45 %
AC0030 / * * *
giving set NaCl - 500 mL
5% glucose, 0.9 %
AC0034 SN * * *
NaCl -500 mL
Injectable
5% glucose in acetate
Glucose 5% in Acetate solution
AC0035 Ringer's Solution in / SN SN SN V
Ringer's Solution with IV
500 mL
giving set
10% in 10-mL
AB0360 Potassium chloride 10% A12BA01 Injection ampoule / * * * V

Injection 500 mL
AC0060
Ringer’s lactate B05BB01 with IV * * * * V
giving set 1000 mL

25
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

0.9% isotonic in 10
/ * * * V
mL ampoule
0.9% isotonic in 100
* * * *
B05XA03 Injectable mL
Sodium chloride (NaCl) B05CB01 solution 0.9% isotonic in 500
/ * * *
mL
0.9% isotonic in 1000
AC0041 * * * *
mL
Sodium hydrogen
carbonate/sodium bicarbonate Injectable 8.4% in 20- mL
AB0380 B05XA02 / * * * V
(NaHCO3) solution ampoule

25.3 Miscellaneous
AB0430 Water for injection Injection 5-mL ampoule SN * * * V
26. VITAMINS AND MINERALS
1 mg (as acetate, as
Hydroxocobalamin (Vitamin hydrochloride or as
B03BA03 Injection / / SN * E
B12) sulfate) in 1-mL
ampoule
AA0340 Multivitamin + Mineral A11AA03 Tablet * * * * N
AA0541
Pyridoxine 10 mg
A11HA02 Tablet * * * * V
NQ1053 (Vitamin B6) 50 mg

AA0490
100 000 IU (as
palmitate)
Retinol (vitamin A) A11CA01 Capsule * * * * V
AA0491
200 000 IU (as
palmitate)
AA0531 Thiamine (Vitamin B1) A11DA01 Tablet 50 mg * * * * E
27. EAR, NOSE AND THROAT MEDICINES
100 micrograms per
Budesonide R01AD05 Nasal Spray / / * * V
dose
Ciprofloxacin S03AA07 Topical 0.3% eye/ear drops * * * * V
Clotrimazole D01AC01 Topical 1% ear drops * * * * V
28. SPECIFIC MEDICINES FOR NEONATAL CARE
28.1 Medicines administered to the neonate
Caffeine citrate N06BC01 Injection 20 mg/ mL / SN SN SN V
28.2 Medicines administered to the mother
4 mg/mL in 1-mL
AB0130 Dexamethasone H02AB02 Injection ampoule (as disodium / * * * V
phosphate salt)

26
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

29. MEDICINES FOR DISEASES OF JOINTS

29.1 Medicines used to treat gout
M04AA0
Allopurinol 1 Tablet 100 mg * * * * V
Colchicine Tablet 600 micrograms / SN * * N
29.2 Disease-modifying agents used to treat rheumatoid arthritis (DMARD's)
Hydroxychloroquine P01BA02 Tablet 200 mg (as sulfate) / / * * V
29.3 Juvenile joint disease
Acetylsalicylic acid N02BA01 Tablet 100 mg * * * * V
30. SPECIALIZED NUTRITION PRODUCTS
Iron-Folate weekly Iron-
60 mg iron element
(WIFS) Folic B03AD03 Tablet * SN SN SN V
+2.8 mg folic acid
Supplementation
410 grams
[ Energy 448Kcal,
Protein 5% energy,
Lipids 31% energy, Vit A
(0.9mg), Vit D (18μg),
Vit E (20mg), Vit C
(59mg), Vit B1 (0.5mg),
Vit B2 (1.2mg), Vit B6
(0.8mg), Folic acid
(200μg), Vit B12 (1.6μg),
Vit K (15μg), Biotin
NL0037 F-75 therapeutic milk - Powder (60μg), Pantothenic acid / / SN SN V
(3mg), Sodium (<87mg),
Calcium (560mg),
Phosphor (330mg),
Potassium (1100mg),
Magnesium (50μg), Zinc
(12.2mg), Iodine
(100μg), Cuivre/Copper
(1.7mg), Selenium
(30μg) and Fer/Iron
(<0.3mg)]

456 grams
[Energy 520Kcal, Protein
>10% of energy, Lipids
>45% of energy, Vit A
(800 μg), Vit D (15 μg),
Vit E (20 mg), Vit C (50
NL0038 F-100 therapeutic milk - Powder / / SN SN V
mg), Vit B1 (0.5 mg), Vit
B2 (1.6 mg), Vit B6 (0.6
mg), Niacin (5 mg), Folic
acid (200 μg), Vit B12
(1.6 μg), Vit K (15 μg),
Biotin (60 μg),

27
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary
 Essential Medicines List (9th Edition, 2018)

V’E’N
CPA1

CPA2

CPA3
MPA
CMS ATC Dosage
Name Strength
code code form

Pantothenic acid (6 mg),

Sodium (<290 mg),
Calcium (300 mg),
Phosphor (300 mg),
Potassium (1100 mg),
Magnesium (80 μg), Zinc
(11 mg), Iodine (70 μg),
Cuivre/Copper (1.4 mg),
Selenium (20 μg) and
Fer/Iron (<0.2 mg)]
1 g [Iron (12.5 mg),
Zinc (10 mg), Vitamin A
(300 μg), Iodine ( 90 μg),
Vit B1 (0.5 mg), Vit B2
(0.5 mg), Vit B6 (0.5
Multiple Micronutrient mg), Vit B12 (0.9 μg),
AA0341 - Powder * SN SN SN V
Powder (MNP) Niacin (6 mg),
Folate/Folic acid (160
μg), Vit C (Ascorbic acid)
(30 mg), Copper (0.3 mg),
Selenium (17 μg), Vit D
(5μg) and Vit E (6 mg)]

510 g

Ready to Use Therapeutic Powder or Energy: 500kcal/100 g

NL0039 - minimum Proteins: 10- SN SN SN SN V
Food biscuits 12% total energy: 12.3-
15.5% by weight Lipids:
45-60% total energy:
24.8-33.3% by weight

42.0 grams in sachet.

Component
Rehydration Solution for Concentration (mmol/l):
NL0030 - Powder / / SN SN V
Malnutrition (ReSoMal) Glucose 125; Sodium 45;
Potassium 40; Chloride
70; Citrate 7; Magnesium
3; Zinc 0.3; Copper 0.045

≈≈≈≈

28
Legend: (*)- available; ( /) - not available; (SN)-special need
V- vital; E-essential, N- necessary